Clinical Trials
5 trialsNCT05176483 2026-05-27
STELLAR-002
Exelixis
Phase 1 Recruiting
NCT02465060 2026-05-26
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
Phase 2 Active not recruiting
NCT06561386 2026-05-20
RELATIVITY1093
Bristol-Myers Squibb
Phase 3 Recruiting
NCT04623775 2025-10-20
A Study of Relatlimab Plus Nivolumab in Combination With Chemotherapy vs. Nivolumab in Combination With Chemotherapy as First Line Treatment for Participants With Stage IV or Recurrent Non-small Cell Lung Cancer (NSCLC)
Bristol-Myers Squibb
Phase 2 Active not recruiting
NCT04205552 2024-05-09
NEOpredict
University Hospital, Essen
Phase 2 Recruiting